A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
St. Luke’s University Health Network’s interventional cardiology team recently debuted the Abbott PressureWire X, the tiniest device ever made for measuring the health and function of the ...
The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in a mid-stage trial, according to data presented at a medical meeting on ...